New England Journal of Medicine
Study
Aug 2013
Patients and professionals
The main trial of vedolizumab (Entyvio) in Crohn's. It helped more people reach remission than placebo by week 6, and people who responded and stayed on it were more likely to be in remission at one year. Side effects, including infections, were somewhat more common than on placebo in this trial.
Topics
Biologics and newer medicines
Jargon explained
integrin
induction
maintenance
serious adverse event
Cochrane
Systematic review
Oct 2015
Patients and professionals
Cochrane pooled the trials of azathioprine and mercaptopurine for keeping Crohn's quiet. Low-quality evidence suggests azathioprine works better than placebo, but side effects such as pancreatitis, low white cell counts, sickness and infections limit its use. More good-quality trials are needed.
Topics
Immunosuppressants
Research
Jargon explained
thiopurine
low-quality evidence
adverse event
remission
placebo
systematic review
NHS
Web page
Mar 2023
For patients
The NHS list of common and serious methotrexate side effects, with tips for coping with sickness, diarrhoea and tiredness. It explains which warning signs of liver, lung, kidney, blood or infection problems need urgent advice, and notes sun sensitivity and possible long-term liver or lung effects.
Topics
Immunosuppressants
Medicines
Jargon explained
anaphylaxis
sun sensitivity
NHS
Web page
Jun 2025
For patients
A general NHS explainer on steroid medicines (corticosteroids), which mimic hormones the body makes and reduce inflammation. It lists Crohn's disease among the conditions treated, explains the different forms steroids come in, and covers common side effects.
Topics
Steroids
Medicines
Jargon explained
corticosteroids
anabolic steroids
NHS
Web page
Oct 2026
For patients
The NHS medicine guide to prednisolone, a steroid that calms inflammation and is used in conditions including Crohn's disease. It covers how to take it, side effects, and why you may be given a blue steroid card and a red steroid emergency card depending on how long you take it.
Topics
Steroids
Medicines
Jargon explained
corticosteroid
steroid emergency card
adrenal insufficiency
Crohn's & Colitis UK
Guide
Aug 2026
For patients
The charity's guide to steroids for Crohn's and Colitis, covering prednisolone, budesonide (brands such as Budenofalk and Entocort) and other forms. It explains side effects, why steroids are only for short-term use, why you must never stop suddenly, how the dose is gradually reduced, the risk of adrenal insufficiency, and carrying a steroid card.
Topics
Steroids
Medicines
Jargon explained
corticosteroids
budesonide
tapering
adrenal insufficiency
steroid card
NHS
Web page
Oct 2026
For patients
NHS medicine guide to azathioprine. It lists skin becoming more sensitive to sunlight as a common side effect, says it may not suit people recently given a live vaccine such as chickenpox or yellow fever, and says it can be used in pregnancy if a specialist recommends it, pointing to the Bumps website for more.
Topics
Immunosuppressants
Cancer risk and screening
Pregnancy and fertility
Medicines
Jargon explained
azathioprine
thiopurine
live vaccine
immunosuppressant
DMARD
bone marrow
The Lancet
Study
May 2022
For professionals
The main international trial of risankizumab injections to keep Crohn's under control after a good response to drip treatment. More people who stayed on risankizumab remained in remission and had gut healing than those switched to placebo, and side effects were similar between groups.
Topics
Biologics and newer medicines
Research
Jargon explained
IL-23
maintenance
placebo
endoscopic response
New England Journal of Medicine
Study
Nov 2016
Patients and professionals
The trials that led to ustekinumab (Stelara) being used for Crohn's. A first drip of ustekinumab helped more people improve than a dummy drip, and injections every 8 or 12 weeks afterwards kept about half of responders in remission at week 44, against about 36% on placebo. Side effects were similar between groups.
Topics
Biologics and newer medicines
Jargon explained
induction
maintenance
IL-12/23
placebo
Cochrane (via PMC)
Systematic review
Apr 2008
Patients and professionals
A Cochrane review confirming standard steroids are effective for bringing active Crohn's into remission. They cause more side effects than placebo, and more research was needed on the best length of treatment and how to reduce them.
Topics
Steroids
Research
Jargon explained
corticosteroids
induction
tapering
NHS
Web page
Sep 2024
For patients
Who is currently offered a COVID-19 vaccine on the NHS, including people with a weakened immune system, how to book, and common side effects.
Topics
Vaccinations and infections
Jargon explained
booster
weakened immune system
Cochrane
Systematic review
Jul 2023
Patients and professionals
Pooling several trials, Cochrane found high-certainty evidence that vedolizumab (Entyvio) works better than placebo both for bringing on remission and keeping it. Overall side effects were probably similar to placebo. Head-to-head comparisons with other biologics are still needed.
Topics
Biologics and newer medicines
Research
Jargon explained
high-certainty evidence
induction
maintenance
integrin